Ibrahim Nor Idawaty, Dahlui M, Aina E N, Al-Sadat N
Ministry of Health, Kuala Lumpur, Malaysia.
Asian Pac J Cancer Prev. 2012;13(5):2213-8. doi: 10.7314/apjcp.2012.13.5.2213.
Worldwide, breast cancer is the commonest cause of cancer death in women. However, the survival rate varies across regions at averages of 73%and 57% in the developed and developing countries, respectively.
This study aimed to determine the survival rate of breast cancer among the women of Malaysia and characteristics of the survivors.
A retrospective cohort study was conducted on secondary data obtained from the Breast Cancer Registry and medical records of breast cancer patients admitted to Hospital Kuala Lumpur from 2005 to 2009. Survival data were validated with National Birth and Death Registry. Statistical analysis applied logistic regression, the Cox proportional hazard model, the Kaplan-Meier method and log rank test.
A total of 868 women were diagnosed with breast cancer between January 2005 and December 2009, comprising 58%, 25% and 17% Malays, Chinese and Indians, respectively. The overall survival rate was 43.5% (CI 0.573-0.597), with Chinese, Indians and Malays having 5 year survival rates of 48.2% (CI 0.444-0.520), 47.2% (CI 0.432-0.512) and 39.7% (CI 0.373-0.421), respectively (p<0.05). The survival rate was lower as the stages increased, with the late stages were mostly seen among the Malays (46%), followed by Chinese (36%) and Indians (34%). Size of tumor>3.0cm; lymph node involvement, ERPR, and HER 2 status, delayed presentation and involvement of both breasts were among other factors that were associated with poor survival.
The overall survival rate of Malaysian women with breast cancer was lower than the western figures with Malays having the lowest because they presented at late stage, after a long duration of symptoms, had larger tumor size, and had more lymph nodes affected. There is an urgent need to conduct studies on why there is delay in diagnosis and treatment of breast cancer women in Malaysia.
在全球范围内,乳腺癌是女性癌症死亡的最常见原因。然而,不同地区的生存率有所差异,发达国家和发展中国家的平均生存率分别为73%和57%。
本研究旨在确定马来西亚女性乳腺癌的生存率及幸存者特征。
对2005年至2009年期间从乳腺癌登记处及吉隆坡医院收治的乳腺癌患者病历中获取的二手数据进行回顾性队列研究。生存数据经国家出生和死亡登记处验证。统计分析采用逻辑回归、Cox比例风险模型、Kaplan-Meier方法和对数秩检验。
2005年1月至2009年12月期间,共有868名女性被诊断为乳腺癌,其中马来人、华人、印度人分别占58%、25%和17%。总体生存率为43.5%(置信区间0.573 - 0.597),华人、印度人和马来人的5年生存率分别为48.2%(置信区间0.444 - 0.520)、47.2%(置信区间0.432 - 0.512)和39.7%(置信区间0.373 - 0.421)(p<0.05)。随着分期增加,生存率降低,晚期患者大多为马来人(46%),其次是华人(36%)和印度人(34%)。肿瘤大小>3.0cm、淋巴结受累、雌激素受体/孕激素受体(ER/PR)及人表皮生长因子受体2(HER 2)状态、就诊延迟和双侧乳房受累等是与生存率低相关的其他因素。
马来西亚乳腺癌女性的总体生存率低于西方数据,其中马来人生存率最低,因为她们就诊时处于晚期,症状持续时间长,肿瘤尺寸大,且受影响的淋巴结更多。迫切需要开展研究,以了解马来西亚乳腺癌女性诊断和治疗延迟的原因。